TRVI — Trevi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Trevi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	45	36.8	121	83	108
Net Total Receivables	0.265	0.241	1.31	0.955	0.867
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46.3	38	123	87.5	109
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.33	0.184	0.194	1.56	1.23
Other Long Term Assets
Total Assets	47.1	38.5	123	89.4	111
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	5.55	12.7	13.4	5.82	10.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.8	21.4	15.6	6.86	11.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	27.3	17.1	107	82.5	99.6
Total Liabilities & Shareholders' Equity	47.1	38.5	123	89.4	111
Total Common Shares Outstanding